Brain complications related to radiotherapy
	    		
		   		
	    	
    	
    	
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Thoi Huu Nguyen
			        		
			        		
		        		
		        		
		        		
		        		
		        		
			        		
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Journal Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		radiotherapy
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Brain;
				        		
			        		
				        		
					        		Radiotherapy
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Journal of Practical Medicine
	            		
	            		 2002;435(11):17-19
	            	
            	
 
            
            
            	- CountryViet Nam
 
            
            
            	- Language:Vietnamese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	The study involved 51 patients with primary brain tumors and 8 patients with brain metastasis from acute leukemia. Age of patients ranged from 5 to 70 years. Drugs for anti-cerebral edema were administered 48 - 72 hours before radiotherapy. For patients with high-volume primary brain tumors, synacthen 1 mL x1 ampoule daily was used and dexamethasone 16-20 mg daily was administered during radiotherapy. For patients with acute leukemia, dexamethasone 8 - 16 mg was used daily. Results: It is possible to prevent from acute cerebral complications if the conventional dose division of radiotherapy is performed appropriately with use of anti-cerebral edema drugs around radiotherapy. The closed monitoring must be given for cases in which chemotherapy, especially methotrexate, was used with radiotherapy